The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
Clinical trial NCT06738160 · RECRUITING
Trial details
- NCT number
- NCT06738160
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-15
- Primary completion
- 2026-12-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.